BRCA2 and breast cancer: During that decade, sentinel lymph node biopsy was introduced as an alternative to full axillary lymph node clearance for the staging of BC, and the specific inherited mutations in the tumour suppressor genes, BRCA1 and BRCA2,1 were identified.